Botulinum Toxin Serotype A randomized double-blind, placebo controlled multicentre study for degenerative coxarthrosis. Studio randomizzato, multicentrico, in doppio cieco controllato con placebo sull'impiego di tossina botulinica di tipo A, nel trattamento della coxartrosi degenerativa.
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms BOLD
- 01 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 20 Jun 2013 New trial record